Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Liver Disease portfolio sales increased 6% to $3.2 billion in the full year 2025, driven by higher demand for Livdelzi and products for chronic hepatitis B virus (HBV) and chronic hepatitis delta virus (HDV), partially offset by lower average realized price in products for chronic hepatitis C virus (HCV)
Epidural or spinal applications, and fluid replacement label contraindications
Sleep quality may improve
gastrointestinal disease (inflammatory bowel disease, celiac disease)
Results A genetic correlation and bidirectional causal association were found between T2D and SA
US$ 24.39
US$ 29.74
US$ 23.43
US$ 26.09
US$ 21.79
US$ 21.53
US$ 25.38
US$ 20.12
US$ 26.54
US$ 23.77
US$ 25.68
